Displaying 26–50 of 10975 results for
At least 17 children in Spain developed a form of “werewolf syndrome” after they were given mislabeled medication.
The FDA is reportedly expanding its investigation related into impurities found in a class of blood pressure medications.
With about 2,000 opioid-related lawsuits looming around the country, Purdue Pharma is reportedly offering to settle for $10-12 billion.
A judge in Oklahoma has ordered Johnson & Johnson to pay $572 million in damages for its role in the opioid epidemic.
Eli Lilly’s Taltz has been given the go-ahead for a new indication, which could help propel the drug to blockbuster status.
Allan Hillgrove, the board member responsible for the company's human pharma and biopharma business, is set to retire at the end of the year as the rest of the Boehringer Ingelheim board is getting shaken up..
Farxiga is being given a speedy review as a method to prevent heart and kidney failure in patients with chronic kidney disease.
Amgen has agreed to buy Celgene’s psoriasis treatment for $13.4 billion in cash, in a deal that will pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene.
Pfizer and partner Astellas announced that the FDA has accepted the supplemental New Drug Application looking for label expansion of cancer drug, Xtandi and granted priority review designation.
pharma manufacturing news in review
Australian researchers from the Centenary Institute and the University of Sydney have successfully developed and tested a new type of vaccine targeting tuberculosis.
BIO 2019 shows how incremental investments make a global impact
Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms
An AstraZeneca immunotherapy has failed to meet its goal in a late-stage study involving patients with advanced non-small cell lung cancer.
Pfizer is injecting $500 million into a manufacturing facility in Sanford, North Carolina to position itself as a bigger player in the gene therapy market.
The organization sent Ningbo Huize Commodity a warning letter for significant current good manufacturing practice violations, including data integrity issues.
The agreement comes ahead of the trial scheduled for October 21, where Purdue, Teva and Johnson & Johnson are still set to face trial.
New approaches to fluid control enhance pharma manufacturing
A potential new blockbuster from AbbVie has gotten the go-ahead from the FDA.
The U.S. FDA has approved Celgene's rare bone marrow cancer drug, Inrebic, giving the drugmaker a big regulatory win ahead of its proposed merger with Bristol-Myers Squibb.
Vanda Pharmaceuticals announced that it has received a complete response letter from the FDA for its potential treatment for jet lag.
Authorities in the Democratic Republic of Congo have confirmed a new case of Ebola in the remote, militia-controlled territory of Walikale
Pfizer has recalled two lots of migraine drug Relpax after finding those lots “may not meet Pfizer’s in-house microbiological specification for the potential presence” of two kinds of bacteria.
The definition of pharma innovation isn’t always clear cut